Robin Riley on Nostr: Phase 1 clinical trials have been approved for a nasal COVID-19 vaccine that blocks ...
Phase 1 clinical trials have been approved for a nasal COVID-19 vaccine that blocks transmission, a novel approach that could be useful for a variety of respiratory infections for which we have vaccines.
Shout out to Washington University in St. Louis for their work on this!
https://www.science.org/doi/10.1126/sciadv.adp1290#COVID #Vaccines #PublicHealth #HealthAndSafety
Published at
2025-02-11 22:26:36Event JSON
{
"id": "c0cedfce596c7634d535f0ec1cbc5134ed2ddbfa15a0b133909e5b7cd7102753",
"pubkey": "2635cb1c07ec759457bbbccef8386cb1cf4afa7553a498c489440d8640f80b91",
"created_at": 1739312796,
"kind": 1,
"tags": [
[
"t",
"covid"
],
[
"t",
"vaccines"
],
[
"t",
"publichealth"
],
[
"t",
"healthandsafety"
],
[
"proxy",
"https://social.riley.pub/users/robin/statuses/113987603425032852",
"activitypub"
]
],
"content": "Phase 1 clinical trials have been approved for a nasal COVID-19 vaccine that blocks transmission, a novel approach that could be useful for a variety of respiratory infections for which we have vaccines.\n\nShout out to Washington University in St. Louis for their work on this!\n\nhttps://www.science.org/doi/10.1126/sciadv.adp1290\n\n#COVID #Vaccines #PublicHealth #HealthAndSafety",
"sig": "61769cb59b61fefc104482fc9718fc00c5cd68779271979d0eb2760463368d87111378b110079e4421187eaadae6978413087e2105da1447f77540194ae77a53"
}
